Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination

Vaccine

Volumn 27, Issue 44, 2009, Pages 6110-6115

  Tharmaphornpilas, Piyanit ^a   Rasdjarmrearnsook, Aim orn ^a   Plianpanich, Saowanee ^b   Sa nguanmoo, Pattaratida ^c   Poovorawan, Yong ^c  

^a Bureau of General Communicable Diseases   (Thailand)

^b Chiangrai Provincial Health Office   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Dose interval; Hepatitis B vaccine; Perinatal transmission

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ARTICLE; CASE CONTROL STUDY; CHRONIC HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; VACCINATION;

CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 70349780376     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.034     Document Type: Article

References (27)

1. World Health Organization. Hepatitis B (Fact sheet no. 204) (2000), World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs204/en/index.html Accessed at: http://www.who.int/mediacentre/factsheets/fs204/en/index.html
2. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 79 (2004) 255-263
3. Beasley R.P., Hwang L.Y., Lee G.C., Lan C.C., Roan C.H., Huang F.Y., et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2 (1983) 1099-1102
4. Pongpipat D., Suvatte V., and Assateerawatts A. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg. Asian Pac J Allergy Immunol 4 (1986) 33-36
5. Beasley R.P., Stevens C.E., Shiao I.S., and Meng H.C. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 2 (1975) 740-741
6. Hyams K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20 (1995) 992-1000
7. Expanded programme on immunization. Global Advisory Group Part II. Wkly Epidemiol Rec 1991;66:9-16.
8. Poovorawan Y., Theamboonlers A., Vimolget T., Sinlaparatsamee S., Chaiear K., Siraprapasiri T., et al. Impact of hepatitis B immunisation as part of the EPI. Vaccine 19 (2000) 943-949
9. Basuni A.A., Butterworth L., Cooksley G., Locarnini S., and Carman W.F. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine 22 (2004) 2791-2799
10. Hsu H.Y., Chang M.H., Ni Y.H., and Chen H.L. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53 (2004) 1499-1503
11. Poovorawan Y., Sanpavat S., Pongpunlert W., Chumdermpadetsuk S., Sentrakul P., and Safary A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 261 (1989) 3278-3281
12. Lee C., Gong Y., Brok J., Boxall E.H., and Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 332 (2006) 328-336
13. Chongsrisawat V., Yoocharoen P., Theamboonlers A., Tharmaphornpilas P., Warinsathien P., Sinlaparatsamee S., et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 11 (2006) 1496-1502
14. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., Chiu T.Y., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135 (2001) 796-800
15. Chunsuttiwat S., Biggs B.A., Maynard J., Thamapalo S., Laoboripat S., Bovornsin S., et al. Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand. Vaccine 15 (1997) 769-774
16. Chunsuttiwat S., Biggs B.A., Maynard J.E., Thammapornpilas P., and O-Prasertsawat M. Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand. Vaccine 21 (2002) 188-193
17. Poovorawan Y., Sanpavat S., Pongpunlert W., Chumdermpadetsuk S., Sentrakul P., Chitinand S., et al. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage. Vaccine 8 (1990) S60-S62
18. Poovorawan Y., Sanpavat S., Pongpunglert W., Chumdermpadetsuk S., Sentrakul P., Vandepapelière P., et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatr Infect Dis J 11 (1992) 816-821
19. Lolekha S., Warachit B., Hirunyachote A., Bowonkiratikachorn P., West D.J., and Poerschke G. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine 20 (2002) 3739-3743
20. World Health Organization. Hepatitis B; prevention and treatment [cited August 18, 2008]. Available from: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index5.html#immunization.
21. Department of Disease Control. Vaccine coverage survey, Thailand 2003 (2004), Ministry of Public Health, Bangkok
22. Poovorawan Y., Theamboonlers A., Sanpavat S., Chongsrisawat V., Willems P., and Safary A. Comparison study of combined DTPw-HB vaccines and separate administration of DTPw and HB vaccines in Thai children. Asian Pac J Allergy Immunol 17 (1999) 113-120
23. Poovorawan Y. Experience of combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B vaccine in Thailand. Southeast Asian J Trop Med Public Health 28 (1997) 496-499
24. Payungporn S., Tangkijvanich P., Jantaradsamee P., Theamboonlers A., and Poovorawan Y. Simultaneous quantitation and genotyping of hepatitis B virus by real-time PCR and melting curve analysis. J Virol Methods 120 (2004) 131-140
25. Poovorawan Y., Theamboonlers A., Chongsrisawat V., and Sanpavat S. Molecular analysis of the a determinant of HBsAg in children of HBeAg-positive mothers upon failure of postexposure prophylaxis. Int J Infect Dis 2 (1998) 216-220
26. Theamboonlers A., Chongsrisawat V., Jantaradsamee P., and Poovorawan Y. Variants within the "a" determinant of HBs gene in children and adolescents with and without hepatitis B vaccination as part of Thailand's Expanded Program on Immunization (EPI). Tohuku J Exp Med 193 (2001) 197-205
27. Poovorawan Y., Hutagalung Y., Chongsrisawat V., Thaemboonlers A., and Lefevre I. Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age. Vaccine 26 (2008) 1535-1540